Hungarian government invests in Kedrion's local plant
This article was originally published in Scrip
Executive Summary
The Hungarian government has invested a non-repayable Ft350 million (€1.3 million) in the local medico-biological company, Human BioPlazma, part of Italy's Kedrion group. The investment will help to upgrade and expand its plant in Godollo near Budapest.